GLP1R and atherosclerosis: GLP-1 RAs have a variety of positive effects on individuals with diabetes, including improving glycaemic control, reducing body weight and BP, ameliorating lipid profiles, decreasing oxidative stress and inflammatory markers, advancing renal outcomes and improving subclinical atherosclerosis and endothelial dysfunction, thereby reducing and possibly preventing cardiovascular events [41].